Combinatorial-Designed EGFR-Targeted Chitosan Nanoparticles for Encapsulation and Delivery of Lipid-Modified Platinum Derivatives in Wild-type and Resistant Non-Small Cell Lung Cancer Cells.

Bibliographic reference: 

Nascimento A.V., Singh A., Bousbaa H., Ferreira D., Sarmento B., & Amiji M.M. (2015). Combinatorial-Designed EGFR-Targeted Chitosan Nanoparticles for Encapsulation and Delivery of Lipid-Modified Platinum Derivatives in Wild-type and Resistant Non-Small Cell Lung Cancer Cells. Moleuclar Pharmaceuticals, 12, pp. 4466-77.